Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
17 studies found for:    "Bannayan-Riley-Ruvalcaba syndrome" OR "Hamartoma Syndrome, Multiple"
Show Display Options
RSS Create an RSS feed from your search for:
"Bannayan-Riley-Ruvalcaba syndrome" OR "Hamartoma Syndrome, Multiple"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed
Has Results
Sirolimus to Treat Cowden Syndrome and Other PTEN Hamartomatous Tumor Syndromes
Conditions: Cowden's Disease;   Hamartoma Syndrome, Multiple
Interventions: Radiation: fludeoxyglucose F 18;   Drug: sirolimus;   Other: Clinical Videography
2 Completed A Phase I/II Study of BEZ235 in Patients With Advanced Solid Malignancies Enriched by Patients With Advanced Breast Cancer
Conditions: Breast Cancer;   Advanced Solid Tumors;   Cowden Syndrome
Intervention: Drug: BEZ235
3 Completed A Phase I/II Study of BGT226 in Adult Patients With Advanced Solid Malignancies Including Patients With Advanced Breast Cancer
Conditions: Solid Tumors;   Breast Cancer;   Cowden Syndrome
Intervention: Drug: BGT226
4 Recruiting French Digestive Polyposis Cohorte Family Adenomatous Polyposis With APC and MYH Gene Mutations , Cowden's Disease With PTEN Gene Mutation, Peutz Jeghers Disease With STK 11 Gene Mutation ,juvénil Polyposis With SMAD 4 Gene Mutation , Serrated and Hyperplastic Polyposis
Condition: Quality of Life
Interventions: Other: Procedure surgery behavioral and genetic diagnosis;   Procedure: quality of life after different type of surgery
5 Recruiting RAD001 and Neurocognition in PTEN Hamartoma Tumor Syndrome (PTEN)
Conditions: PTEN Gene Mutation;   PTEN Hamartoma Tumor Syndrome
Interventions: Drug: RAD001;   Drug: Placebo
6 Recruiting Photodynamic Therapy and Vismodegib for Multiple Basal Cell Carcinomas
Condition: Basal Cell Carcinoma
Intervention: Drug: Vismodegib
7 Active, not recruiting
Has Results
A Study of Two Vismodegib Regimens in Participants With Multiple Basal Cell Carcinomas
Condition: Basal Cell Carcinoma
Interventions: Drug: Vismodegib;   Drug: Placebo
8 Recruiting Natural History Study of Individuals With Autism and Germline Heterozygous PTEN Mutations
Conditions: PTEN;   ASD;   Autism;   Macrocephaly;   PTEN Hamartoma Tumor Syndrome
Intervention:
9 Completed Trial Comparing the Effects of Intermittent Vismodegib vs. PDT in Patients With Multiple Basal Cell Carcinomas
Conditions: Basal Cell Nevus Syndrome;   Gorlin's Syndrome
Interventions: Drug: Vismodegib;   Drug: Aminolevulinic acid %20 topical solution
10 Terminated Two Studies to Determine if Verteporfin PDT is Effective & Safe in Treating Multiple Basal Cell Carcinoma of the Skin.
Conditions: Basal Cell Carcinoma;   Nevoid Basal Cell Carcinoma Syndrome;   Gorlin Syndrome
Intervention: Drug: verteporfin PDT
11 Completed The Evaluation of Oral Acitretin in the Treatment of Psoriasis, Cutaneous Disorders of Keratinization, Multiple Basal Cell Carcinomas and Other Retinoid Responsive Diseases
Conditions: Basal Cell Carcinoma;   Keratosis Palmaris et Plantaris;   Psoriasis
Intervention:
12 Recruiting Familial Investigations of Childhood Cancer Predisposition
Conditions: Acute Leukemia;   Adenomatous Polyposis;   Adrenocortical Carcinoma;   AML;   BAP1 Tumor Predisposition Syndrome;   Carney Complex;   Choroid Plexus Carcinoma;   Constitutional Mismatch Repair Deficiency Syndrome;   Diamond-Blackfan Anemia;   DICER1 Syndrome;   Dyskeratosis Congenita;   Emberger Syndrome;   Familial Acute Myeloid Leukaemia;   Familial Adenomatous Polyposis;   Fanconi Anemia;   Familial Cancer;   Familial Wilms Tumor;   Familial Neuroblastoma;   GIST;   Hereditary Breast and Ovarian Cancer;   Hereditary Paraganglioma-Pheochromocytoma Syndrome;   Hodgkin Lymphoma;   Juvenile Polyposis;   Li-Fraumeni Syndrome;   Lynch Syndrome;   MDS;   Melanoma Syndrome;   Multiple Endocrine Neoplasia Type 1;   Multiple Endocrine Neoplasia Type 2;   Neuroblastoma;   Neurofibromatosis Type 1;   Neurofibromatosis Type II;   Nevoid Basal Cell Carcinoma Syndrome;   Non Hodgkin Lymphoma;   Noonan Syndrome and Other Rasopathy;   Overgrowth Syndromes;   Pancreatic Cancer;   Peutz-Jeghers Syndrome;   Pheochromocytoma/Paraganglioma;   PTEN Hamartoma Tumor Syndrome;   Retinoblastoma;   Rhabdoid Tumor Predisposition Syndrome;   Rhabdomyosarcoma;   Rothmund-Thomson Syndrome;   Tuberous Sclerosis;   Von Hippel-Lindau Disease
Intervention:
13 Recruiting Study of ARQ 092 in Patients With Overgrowth Diseases and Vascular Anomalies
Conditions: Proteus Syndrome;   PIK3CA-Related Overgrowth Spectrum (PROS);   Growth Disorders
Intervention: Drug: ARQ 092
14 Enrolling by invitation Dose Finding Trial of ARQ 092 in Children and Adults With Proteus Syndrome
Condition: Proteus Syndrome
Intervention: Drug: ARQ 092
15 Completed Informed Consent for Whole Genome Sequencing: Ideals and Norms Referenced by Early Participants
Conditions: Coronary Artery Disease;   Proteus Syndrome;   Coffin - Sins Syndrome;   Familial Isolated Hyperparathyroidism;   Dubouitz Syndrome
Intervention:
16 Recruiting Study of Proteus Syndrome and Related Congenital Disorders
Conditions: Growth Disorder;   Mental Retardation;   Multiple Abnormalies
Intervention:
17 Active, not recruiting Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian Cancer
Conditions: Familial Ovarian Cancer;   Familial Breast Cancer;   BRCA1-associate Malignancies;   BRCA2-associated Malignancies
Intervention:

Study has passed its completion date and status has not been verified in more than two years.